samedan logo
 
 
 
spacer
home > pmps > summer 2003 > digital watermarking for protection of pharmaceutical packaging
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digital Watermarking for Protection of Pharmaceutical Packaging

The problem of pharmaceutical falsification is well documented if not well tracked. It is assumed that the reader understands the nature of the problem and the impact on public health, corporate reputation, brand image and the financial bottom line. Any single incident of falsification can negatively affect all four. Published information from sources including the World Health Organization, US congressional hearings and the International Chamber of Commerce estimate the international trafficking in falsified drugs as high as six per cent of international pharmaceutical sales, and over 50 per cent in some African countries.

The word falsification is used because a significant percentage of illegal trade is in genuine product that has been otherwise mislabelled, diverted or had expiration dates altered. Falsification may cover one of the following activities:


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By J Scott Carr, President of Digimarc Watermarking Solutions

J Scott Carr has more than 18 years' experience in sales and business development, strategic marketing and software development, with a focus on complex systems, security, electronic commerce and interactive media. Mr Carr joined Digimarc in 1996.

Today, as President of Digimarc Watermarking Solutions, he oversees all aspects of the company's digital watermarking operation, which includes engineering, R&D, sales, marketing and finance organisations, delivery of digital watermarking solutions focused on financial services, secure ID and digital image management. Previously, he was responsible for Digimarc's digital watermarking business in the financial systems market, including management of a multi-year anticounterfeiting project with an international consortium of central banks.

spacer
J Scott Carr
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Axol Bioscience introduces multi-electrode array screening services for human iPSC-derived cells

• Expansion of Axol Bioscience’s service offering for pre-clinical drug discovery • New services combine the Company’s iPSC-derived human cells and electrophysiological expertise with Axion Biosystems’ Maestro Pro MEA platform
More info >>

White Papers

RSSL introduces same-day mycoplasma testing service in UK

RSSL

Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical, and biopharmaceutical sectors, has introduced the United Kingdom’s first same-day mycoplasma testing service for manufacturers of biologic medicines.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement